The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance.

Chun-Li Yin, Yu-Jie Ma

Journal: Current molecular pharmacology 2024;17():e18761429266116

PMID: 38389420

Abstract

Hypoxia-inducible factor (HIF) is a nuclear protein that plays a crucial role in oxygen homeostasis through its transcriptional activity and thousands of target gene profiles. Through transcriptional and post-transcriptional regulation, the downstream target genes of HIF can trigger multiple pathological responses in the body, including energy metabolism, cytopenia, and angiogenesis. There are three distinct subtypes of HIF: HIF-1, HIF-2, and HIF-3. HIF-1 is a significant regulator of the cellular response to hypoxia, and the balance between its production and degradation is critical for this response. As hypoxia is linked to several disorders, understanding HIF can open up novel avenues for the treatment of many diseases. This review describes the regulatory mechanisms of HIF-1 synthesis and degradation and the clinical significance of the hypoxia-inducible factor pathway in lung injury, kidney disease, hematologic disorders, and inflammation-related diseases.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Air Force Clinical College of Anhui Medical University, The Fifth Clinical College of Anhui Medical University, Hefei 230032, China.; Department of Critical Care Medicine, PLA Air Force Medical Center, Beijing 100142, China.

Link outs

Free resources

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.